Retroperitoneal liposarcomas: Follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas

Cancer

Volumn 106, Issue 12, 2006, Pages 2725-2733

  Fabre Guillevin, Elizabeth ^a   Coindre, Jean Michel ^b   De Saint Aubain Somerhausen, Nicolas ^c   Bonichon, Francoise ^b   Stoeckle, Eberhard ^b   Bui, Nguyen Binh ^b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSTITUT BERGONIÉ   (France)

^c JULES BORDET INSTITUTE   (Belgium)

Author keywords

Dedifferentiated liposarcoma; Dedifferentiation; Malignant fibrous histiocytoma; Retroperitoneum; Sarcoma; Well differentiated liposarcoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CLINICAL FEATURE; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR DIFFERENTIATION;

ADULT; AGED; CELL DIFFERENTIATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; LIPOSARCOMA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33745217875     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21933     Document Type: Article

References (38)

1. Dei Tos AP. Liposarcoma: new entities and evolving concepts. Ann Diagn Pathol. 2000;4:252-266.
2. Lucas DR, Nascimento AG, Sanjay BK, Rock MG. Well-differentiated liposarcoma. The Mayo Clinic experience with 58 cases. Am J Clin Pathol. 1994;102:677-683.
3. Linehan DC, Lewis JJ, Leung D, Brennan MF. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol. 2000;18:1637-1643.
4. Enzinger FM, Weiss SW. Liposarcoma: Soft Tissue Tumors. 3rd ed. St. Louis: CV Mosby; 2001.
5. Fletcher CDM. Unni K, Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: International Agency for Research on Cancer (IARC); 2002.
6. Evans HL. Liposarcoma. A study of 55 cases with a reassessment of its classification. Am J Surg Pathol. 1979;3:507-523.
7. Henricks WH, Young CC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma. A clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21:271-281.
8. McCormick D, Mentzel T, Beham A, Fletcher CD. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol. 1994;18:1213-1223.
9. Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol. 2001;19:3045-3050.
10. Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 1559 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol. 1992;16:2113-2118.
11. Hollowood K, Fletcher CDM. Malignant fibrous histiocytoma: morphologic pattern or pathologic entity? Semin Diagn Pathol. 1995;12:210-220.
12. Derre J, Lagace R, Nicolas A, et al. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest. 2001;81:211-215.
13. Chibon F, Mariani O, Derre J, et al. A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet. 2002;139:24-29.
14. Coindre JM, Mariani O, Chibon F, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol. 2003;16:256-262.
15. Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation." Am J Surg Pathol. 1992;16:1051-1058.
16. Azumi N, Curtis J, Kempson RL, Hendrickson MR. Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases. Am J Surg Pathol. 1987;11:161-163.
17. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001;91:1914-1926.
18. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames, IA: Iowa State University; 1980.
19. Altman DG. Practical Statistics for Medical Research. 1st ed. London: Chapman & Hall; 1991.
20. Wilcoxon F. Individual comparisons by ranking methods. Biometr Bull. 1945;1:80-86.
21. Cox DR. Regression model and life table (with discussion). J R Stat Soc. 1972;34187-34190.
22. Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft tissue sarcomas. Ann Surg. 1991;214:2-10.
23. Cody HS 3rd, Turnbull AD, Former JG, Hajdu SI. The continuing challenge of retroperitoneal sarcomas. Cancer. 1981; 47:2147-2152.
24. Jaques DP, Coit DG, Hajdu SI, Brennan MF. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg. 1990;212:51-59.
25. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma. Analysis of 500 patients treated and followed at a single Institution. Ann Surg. 1998;228:355-365.
26. Bautista N, Su W, O'Connell X. Retroperitoneal soft tissue sarcomas prognosis and treatment of primary and recurrent disease. Am Surg. 2000;66:832-836.
27. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognosis factors in retroperitoneal sarcomas: a multivariate analysis of a serie of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92;359-368.
28. Kilkenny JW, Bland KI, Copeland EM. Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg. 1996;182:329-339.
29. Catton CN, O'Sullivan B, Kotwall C, Cummings B, Hao Y, Fornasier V. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1994;29:1005-1010.
30. Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238:358-370.
31. Bevilacqua RG, Rogatko A, Hajdu SI, Brennan MF. Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg. 1991;126:328-334.
32. Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol. 1997;15:2832-2839.
33. Alvarenga JC, Ball AB, Fisher C, Fryatt I, Jones L, Thomas JM. Limitations of surgery in the treatment of retroperitoneal sarcoma. Br J Surg. 1991;78:912-916.
34. Elgar F, Goldblum JR. Well-differentiated liposarcoma of the retroperitoneum: a clinicopathologic analysis of 20 cases, with particular attention to the extent of low-grade dedifferentiation. Mod Pathol. 1997;10:113-120.
35. Coindre JM, Hostein I, Maire G, et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol. 2004;203:822-830.
36. Dal Cin P, Kools P, Sciot R, et al. Cytogenetic and fluorescence in situ hybridisation investigation of ring chromosomes characterising a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet. 1993;68: 85-90.
37. Pedeutour F, Suijkerbuijk RF, Forus A, et al. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer. 1994;10: 85-94.
38. Rubin BP, Fletcher CDM. The cytogenetics of lipomatous tumours. Histopathology. 1997;30:507-511.